HKU Demo Day @ HKTDC E-Day
Event Details:
HKU Demo Day offers a dynamic platform where promising startups will deliver pitches on their business plans and latest progress—serving as an exceptional opportunity to connect with venture capital (VC) investors, who will share valuable feedback to fuel the teams’ growth.
We cordially invite you to join this special HKU Demo Day x HKTDC E-Day, where HKU startups will present their business plans and recent progress to a wide network of industry partners and investors in person.
Key Event Highlights:
- Pitch Format: Each startup will deliver a focused 5-minute pitch + 3-minute Q&A to present their vision and progress.
- Networking Opportunities: The event is part of the Hong Kong Trade Development Council (HKTDC)’s Entrepreneur Day and is expected to attract over 10,000 professionals. Entrepreneurs will gain significant exposure through both the booth display and pitching sessions.
- Other Benefits: Selected winning teams will receive co-working space support from iDendron to further their operations.
Let’s anticipate an inspiring showcase of innovation and entrepreneurship!
Date: 4 December 2025 (Thursday)
Time: 10:20 – 11:30
Venue: Hall 1C, HKCEC
Language: English/ Mandarin
Guest Registration Link: https://forms.office.com/r/Wq0dnjPzJE
Official E-Day Pass (Click To Visit): https://www.hktdc.com/event/eday/en
(We kindly encourage you to complete your registration in advance via the official HKTDC website to facilitate a smooth entry on the event day.)
Tentative Rundown
| Time | Description |
| Tech-Up GBA Innovators Programme Award Ceremony | |
| 10:00 – 10:05 | Opening Remarks by Prof Stephanie Ma, Associate Vice-President (Research and Innovation) |
| 10:05 – 10:10 | Speech by Dr Paul Wang, Director of Techno-Entrepreneurship Core |
| 10:10 – 10:15 | Tech-up GBA Innovator Programme Results Announcement |
| 10:16 – 10:20 | Group Photo |
| HKU Demo Day | |
| 10:20 – 11:30 | Start-up Pitching (5 mins Presentation + 3 mins Q&A)
|
Booth showcase:
| Company Name (in English) | Short Description | Academic PIC | Representative |
| DeepSonix Limited | DeepSonix provides ultrafast ultrasound microscopy that detects micron-level defects in 3D chips in seconds—not hours. Our AI-powered solution enables 100% inspection in high-volume manufacturing, slashing scrap costs and material waste while accelerating the adoption of advanced semiconductor packaging. | Bingze Dai | Bingze Dai |
| Cinnotis Limited | Cinnotis Limited is a biopharmaceutical startup focused on developing cinnamaldehyde-based nanomedicines for rheumatoid arthritis and other inflammatory diseases. Its core technology incorporates cinnamaldehyde-based reactive oxygen species (ROS)-responsive prodrug design and self-assembly nanotechnology, enabling targeted drug release at inflammatory sites. This approach enhances efficacy and reduces systemic toxicity. The company has completed key preclinical studies, secured four international patents, and won multiple awards, including a Gold Medal at the Geneva International Exhibition of Inventions. Cinnotis aims to license its technology to pharmaceutical partners for global commercialization, offering a safer and more cost-effective treatment option for inflammatory diseases. | Weiping WANG | Shuxian WEN |
| ReGen Technology Holdings Limited | ReGen Technology is a Hong Kong–based climate tech venture developing patented, solar-powered desalination systems that produce fresh water just with the power of the sun at low cost. Founded in 2024, the company enables water access and land regeneration in coastal, arid, and climate-stressed regions by converting seawater into drinkable or irrigation-grade water while recovering valuable minerals. ReGen’s modular, off-grid units are designed for scalable deployment across agriculture, remote communities, disaster zones, and regenerative development projects. The venture is currently advancing pilot sites in Morocco, Cyprus, and Southeast Asia, supported by research partners and early interest from leading climate-focused investors. | Julian Gaertner | Julian Gaertner |
| FANS DEFIN CO., LIMITED | FanFi is a Hong Kong-based digital asset platform linking Mainland China’s creator economy withHong Kong’s regulated virtual-asset market. Centered on “Fan Defined,” the company hasestablished three Hong Kong-based matrix subsidiaries for branding and market outreach, and nineMainland entities for traffic generation, community building, and collaborations with localgovernments and art institutes. In the next phase, FanFi plans to expand to eleven additional Mainland cities, covering key first- and second-tier markets to reinforce its ecosystem matrix. Through NFT and STO mechanisms, FanFi transforms music, film, and art works into verifiable and investable digital assets, bridging creativity and capital. | Han Wenqing | Han Wenqing |
| Dr.SisLab |
Dr.SisLab is a biotech startup leveraging menstrual blood—a unique biological sample offering deep insights into women’s health—and advanced AI analytics to build a digital platform for accessible, data-driven, and personalized wellness management.
Our initial offering provides convenient, reliable inflammation assessment, individualized health risk analysis, and actionable guidance—helping women monitor inflammation and improve long-term wellness. Meanwhile, we’re building a proprietary menstrual health database that powers innovation in femtech and AI-driven precision health.
|
Boya Liao | Boya Liao |
| ReMobility Limited |
With over 2.5 billion people needing rehabilitation, global access is limited. SmartRehab, developed by HKU, tackles this using AI and computer vision. A device’s camera enables precise motion tracking without wearables, making telerehabilitation accessible and validated against gold-standard systems.
The platform offers motor exercises, allowing patients to train at home while therapists monitor progress and personalize treatment remotely. Supported by the World Stroke Organization, its feasibility is proven across eight international institutions.
|
Gary Lau Kui Kai | Ada Tse |
| OpluxCare Tech Group Limited | OpluxCare Tech Group Limited pioneers non-invasive physiological detection using confocal Raman spectroscopy combined with AI algorithms and precision optics. Our portable devices achieve medical-grade accuracy without blood sampling, enabling real-time, painless monitoring of biomarkers such as glucose, uric acid, and lipids. Integrating confocal Raman design, deep-cooled detectors and CNN, OpluxCare delivers superior signal-to-noise ratio and predictive precision, providing a breakthrough alternative to invasive testing. The company targets both B2B and B2C healthcare markets, including hospitals, elderly care facilities, pharmacies, and home users. Business models include equipment sales, leasing, and data-driven subscriptions. Collaborating with NJU, Accelink (SZ.002281), and clinical partners, OpluxCare is advancing toward Class II medical device certification in China, led by Dr. Hongyi Wu and Prof. Xinglong Wu with their expertise across AI analytics and Raman spectroscopy. | Hongyi WU | Hongyi WU |
| Tomorrow’s Brain Limited |
Tomorrow’s Brain is an innovative EdTech company that leverages educational neuroscience, artificial intelligence, and psychological learning theories to advance Precision Education.
Our pioneering product, I-DID (Intelligent Dyslexic Interface Design), is an AI-powered integrated Chinese and English assessment and learning system, tailored specifically for 4- to 12-year-old children. The system is designed and implemented to optimize the traditional diagnostic and intervention workflow, eliminating delayed, inefficient, and unsustainable provision of services, with the following core functions:
(1) Delivers precise assessment and sustainable training focusing on Chinese and English foundational literacy skills;
(2) Timely generates multifactorial learning profiles upon completion of assessment; and
(3) Recommends adaptive training schemes based on individuals’ strength-weakness profiles.
|
Shelley Xiuli Tong | Sochi Liu |
| Sharpsight Limited | Sharpsight develops AI-powered intelligent rehabilitation solutions addressing facial, upper-limb, and lower-limb dysfunction caused by neurological disorders. Our flagship product line, masquer®, leverages multimodal sensing—including computer vision, motion capture, EEG, and EMG—to assess facial asymmetry, emotional expression, and motor function with clinical-grade accuracy. By generating real-time facial reconstruction and virtual mirroring, masquer® activates neural pathways and supports motor relearning for stroke, facial paralysis, and mental-health-related expression deficits. Our technologies have been deployed across 50+ hospitals and rehabilitation institutions, backed by 20+ academic publications and 30+ patents. We aim to redefine rehabilitation through AI-driven, personalized digital therapeutics and scalable telerehabilitation platforms. | Dr Zhimin Xu | |
| Metasurgical Technology Limited |
This project, developed by Metasurg, delivers an intelligent, non-surgical solution for musculoskeletal (MSK) and spinal conditions like scoliosis. Its core innovation is the mskalign® iwearable system and device, which integrates the 4DOrtho smart wearable for continuous body alignment monitoring with the AlignPro AI software platform for personalized exercise therapy.
The system is powered by a unique, data-driven hybrid AI model, trained on a vast, real-world patient dataset annotated by clinical experts. It provides comprehensive monitoring of key metrics (e.g., Cobb angle, ATR) and dynamic treatment assessment, significantly improving patient compliance and outcomes. The project has achieved regulatory approval (NMPA) and initial commercialization in China.
|
Teng Zhang | Kuang Xihe |
| DiamNEX Ltd. | DiamNEX has developed a globally pioneering ” Edge-Exposed Exfoliation” technique to produce wafer-scale, ultra-flat, and ultra-thin polycrystalline diamond films. This innovative method bypasses the traditional, costly, and time-consuming challenges of cutting, etching, and polishing diamond wafers. The technology can produce 2-inch (and scalable) membranes with sub-nanometer surface roughness, making them perfectly compatible with existing semiconductor manufacturing processes. | CHU Zhiqin | CHU Zhiqin |
| Inhalixir Limited | Inhalixir is transforming health management with inhaled supplements, starting with probiotics. Leveraging advanced particle engineering techniques, we achieve efficient lung deposition while maintaining probiotic viability and stability. We demonstrated that inhaled probiotics significantly reduce viral load in the lungs, which is promising for preventing respiratory viral infections. With over 30 million flu cases annually in China, our product addresses a critical need for effective flu prevention among populations exposed to high viral transmission risk in dense urban areas. Beyond flu prevention, our business will grow with the expanding wellness market with our extended consumer respiratory health solutions. | Aviva Chow Shing Fung | Seow Han Cong |
| NexaSight Limited |
NexaSight is a biotech startup originating from The University of Hong Kong, dedicated to revolutionizing precision pathology through its next-generation ultra-high resolution imaging platform. The company’s core technology addresses critical bottlenecks in traditional pathology, including high costs, complex workflows, imprecise diagnoses, and elevated patient risks.
NexaSight provide comprehensive solutions for both research and clinical pathology markets, offering sample testing services, specialized reagents and consumables, and integrated hardware with Al-powered software.
Through a phased market expansion strategy, NexaSight aims to establish itself as a global leader in imaging solutions, delivering transformative technology that bridges the gap between research innovation and clinical application in pathology.
|
Haibo Jiang | Haibo Jiang |